BillionToOne

YC S17 · 500 Global 2017 · Public · The genetic testing platform detecting and measuring disease.

Competitors

Companies closest to BillionToOne
Company	Category	Status	Program
Luminist LabsShared: non invasive, genomics, diagnosticsAcquiredOther	Other	Acquired	YCW16
DarmiyanShared: non invasive, diagnostics, diseaseActiveAI	AI	Active	YCS17
Kenota (formerly ExVivo Labs)Shared: diagnostics, disease, testInactiveOther	Other	Inactive	YCS16
Sigma GeneticsShared: non invasive, genomics, dnaActiveOther	Other	Active	YCW17
DeleeShared: diagnostics, testing, bloodActiveOther	Other	Active	YCW17

Adjacent

Companies next to BillionToOne
Company	Category	Status	Program
MoichorShared: diagnosticsActiveAI	AI	Active	YCW21
Haplotype LabsShared: genetic testing, disease, availableActiveAI	AI	Active	YCW24
LSK TechnologiesShared: diagnosticsAcquiredOther	Other	Acquired	YCS20
Probably GeneticShared: genomics, genetic, diseaseActiveAI	AI	Active	YCW19
UnimaShared: diagnostics, disease, developedInactiveOther	Other	Inactive	YCW16

Also from S17

All of S17

Company	Category	Status
Cambridge Cancer GenomicsCCG.ai empowers clinicians to make personalised treatment strategies…InactiveAI	AI	Inactive
10 By 1010by10 is a unique marketplace in the recruiting agency industry for…ActiveAI	AI	Active
AssemblyAIThe best way to build Voice AI appsActiveAI, Devtools	AI, Devtools	Active
Cairns HealthYour voice. Your health. We care.ActiveAI	AI	Active
CandidatelyThe digital storefront for staffing and recruiting teams.ActiveAI	AI	Active
Commissary Club (formerly 70 Million Jobs)First agentic AI-powered community for 1 billion people with criminal…InactiveAI	AI	Inactive

Programs

Programs BillionToOne went through
Program	Cohort	Source
Y Combinator	S17 · Summer 2017	YC Page
500 Global	2017	500 Global Page

About BillionToOne

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

YC batch: S17 · Summer 2017
Status, per YC: Public
Category: Other
Team size: 300
Location: San Francisco, CA, USA; Menlo Park, CA, USA
Checked: 1h ago

YC tags: Diagnostics, Genomics

BillionToOne in S17: 125 companies, 26% AI

BillionToOne: questions

Which YC batch was BillionToOne in?

BillionToOne was in Y Combinator's Summer 2017 batch (S17).

Which accelerators did BillionToOne go through?

BillionToOne is listed by Y Combinator (S17), 500 Global (Global 2017).

Is BillionToOne still active?

Y Combinator lists BillionToOne as public.

Where is BillionToOne based?

BillionToOne lists San Francisco, CA, USA; Menlo Park, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.